This site is intended for UK Healthcare professionals only

Are you a UK Healthcare professional?

We are unfortunately unable to allow patients to attend CPC London

Manchester Event

Conference Programme 2024

Subpage Hero

.

Loading

Psychotropic Medication in Children and Young People’s Mental Health In-patient Services

10 May 2024
Leadership & Professional Development Theatre
Psychotropic Medication in Children and Young People’s Mental Health In-patient Services

The prevalence of mental health problems for children and young people is rising significantly as is the prescribing of psychotropic medications. This issue is important for all primary and secondary care pharmacists. Concerns about overprescribing, limited review and psychotropic polypharmacy are key findings of the Psychotropic Medication in Children and Young People’s Mental Health In-patient Services quality improvement programme. This team presentation will not only provide the findings of the programme but also present the views of the young people themselves and of the parent carers.

Speakers
David Branford, Independent Pharmacy Consultant (mental health and intellectual disabilities) - Contracted to Quality Transformation Team, NHS England
Anne Webster, Lead - Psychotropic Medication in Children and Young People’s Mental Health Inpatient Services Project - Working on behalf of the Quality Transformation Team NHS England
Teresa Randon, Lived Experience Co-worker, Children and Young People: Learning Disability and Autism Programme - NHS England and NHS Improvement
David Gill, Lived Experience Adviser, Children and Young People, Learning Disability Programme - NHS England
Kirsten PEEBLES, Co-chair of the Building the Right Support Advisory Group (representing families) - Independent Lived Experience Expert

Newsletter Sign Up